A new research centre backed with £11 million from GSK will build open-source digital twins of organs for in-silico research to advance disease understanding and speed up development of new drugs. The Modelling-Informed Medicine Centre (MiMeC), founded by the biopharma company GSK and the University of Oxford and Imperial College London, will provide a new UK hub for research in the rapidly growing field of data-driven mechanistic modelling. The centre will create computer models or ‘digital

Tag-uri: GSK